organization structure

Chairman: Xiong Yuqing

Vice Chairmen: Cao Cai, Xiu Qing Yu, Cui Yimin, Liang Maozhi, Li Haiyan, Wang Shaohua and Li Jianming.

Secretary General: Wang Shaohua

Deputy Secretaries-General: Xia Chunhua, Zhao Yan and Xiuli Zhao.

Standing Committee: (35 people, sorted by surname strokes)

Ma Jinchang,, Fang Yi,,,,,,

Li,,, Li Chaowu, Xu Chongyuan,, jiang bo, Yu Xiyong,

Xiu Qing Yu,,, Zhao Jun, Hong,, Xia Peiyuan, Xia Chunhua, Xu Guili,

Cao Cai, Cui Yimin, Liang Maozhi, Huang Jianying, Zhao, Miao Liyan, Xiong Yuqing, Wei

Member: (8 1 person, sorted by surname strokes, including the Standing Committee)

Ding Jinbiao, Ma Jinchang,,,, Fang Yi, Wen,.

Sun Ruiyuan, Sun,,,, Bi Jingfeng,,, Li Kexin

Li, Li Chaowu, Li Yang, Li Ling, Xu Chongyuan.

, Liu, Liu Lizhong, Liu, Tang Jianlin, jiang bo, Yu Xiyong, Xin

Zhang Jing, Zhang Huijie, Zhang Yuanyuan, Zhang Qingyuan, Wang Xiuqin, Du Zhimin, Yan Pengke, Chen Yongchuan, Chen Ying.

Lin Ling, Mao Yimin, Xiu Qing Yu,,, Zhao Jun, Zhao Yan, Zhao and Hong.

Jiang Min, Guo Yubiao, Zhou Shiwen, Jin Xiaoqing, Xia Peiyuan, Xia Chunhua, Hu Xiao, Hu Siyuan, Xu Guili.

Cao Cai, Cao, Cui Yimin, Liang Maozhi, Liang Yan, Xu Pingsheng, Huang Jianying, Huang Xuemei, Jiang Meng.

Zeng, Tong, Xie Haitang, Zhao, Miao Liyan, Xiong Yuqing, Wei

Brief introduction of the professional Committee of drug clinical trials of Chinese Pharmacology Society

The Professional Committee of Drug Clinical Trials of Chinese Pharmacology Society is committed to the construction of drug clinical trial management system and academic and technical exchanges, bringing together major academic leaders and experienced frontline workers in the field of drug clinical trials in China. By building this platform, it will help research institutions to exchange and share valuable experience in the operation and management of drug clinical trials, improve the quality management system of drug clinical trials in China, build a research and evaluation technology system of drug clinical trials in line with international standards, strengthen mutual cooperation, and jointly promote the progress and development of drug clinical trials in China.

Specialized committees for drug clinical trials will take different forms to organize people from all walks of life to conduct academic discussions on new technologies, new methods and new operation and management of drug clinical trials, jointly explore the operation and management mode suitable for drug clinical trial institutions in China, promote the scientific and standardized operation of drug clinical trials in China, and build a drug clinical trial platform in line with international standards; Integrate the superior resources of drug clinical trial institutions to promote inter-agency cooperation and resource sharing; Give full play to experts' expertise, assist SFDA to formulate relevant management policies and technical specifications for drug clinical trials, and actively put forward suggestions for drug clinical trials to relevant departments; Strive to develop and actively recommend the scientific and technological achievements, academic papers and professional works of the members of the professional Committee of drug clinical trials, and promote the continuous development and growth of the society; Comprehensively enhance the popularity and international competitiveness in the field of drug clinical trials in China, and create the most convenient, real-time, mutual benefit and mutual trust communication platform for the research, clinical application and operation management of drug clinical trials in China.

Further reading: How to buy insurance, which is good, and teach you how to avoid these "pits" of insurance.